IBRX vs. SILJ

Last updated Jun 5, 2026

IBRX (ImmunityBio, Inc.) is a stock, while SILJ (Amplify Junior Silver Miners ETF) is Silver fund tracking the Nasdaq Junior Silver Miners Index. Over the past 10 years, IBRX returned -0.62%/yr vs 9.81%/yr for SILJ. At a 0.16 correlation, their price movements are largely independent.

Performance

IBRX vs. SILJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ImmunityBio, Inc. (IBRX) and Amplify Junior Silver Miners ETF (SILJ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, IBRX achieves a 268.18% return, which is significantly higher than SILJ's 7.05% return. Over the past 10 years, IBRX has underperformed SILJ with an annualized return of -0.62%, while SILJ has yielded a comparatively higher 9.81% annualized return.

IBRX

• 1D: 1.53%
• 1M: -3.83%
• YTD: 268.18%
• 6M: 216.96%
• 1Y: 148.81%
• 3Y*: 37.73%
• 5Y*: -16.08%
• 10Y*: -0.62%

SILJ

• 1D: 0.41%
• 1M: 3.93%
• YTD: 7.05%
• 6M: 17.56%
• 1Y: 109.13%
• 3Y*: 47.92%
• 5Y*: 13.22%
• 10Y*: 9.81%

*Multi-year figures are annualized to reflect compound growth (CAGR)

IBRX vs. SILJ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
IBRX ImmunityBio, Inc.	268.18%	-22.66%	-49.00%	-0.99%	-16.61%	-54.39%	251.72%	226.72%	-74.16%	-21.50%
SILJ Amplify Junior Silver Miners ETF	7.05%	183.89%	6.39%	-5.21%	-15.42%	-23.21%	33.00%	57.06%	-27.95%	-5.65%

Correlation

The correlation between IBRX and SILJ is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.25
Correlation (3Y) Calculated over the trailing 3-year period	0.21
Correlation (5Y) Calculated over the trailing 5-year period	0.22
Correlation (10Y) Calculated over the trailing 10-year period	0.18
Correlation (All Time) Calculated using the full available price history since Jul 29, 2015	0.16

Return for Risk

IBRX vs. SILJ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBRX

IBRX Risk / Return Rank: 81
IBRX Sharpe Ratio Rank: 80
IBRX Sortino Ratio Rank: 84
IBRX Omega Ratio Rank: 81
IBRX Calmar Ratio Rank: 86
IBRX Martin Ratio Rank: 76

SILJ

SILJ Risk / Return Rank: 55
SILJ Sharpe Ratio Rank: 61
SILJ Sortino Ratio Rank: 48
SILJ Omega Ratio Rank: 52
SILJ Calmar Ratio Rank: 65
SILJ Martin Ratio Rank: 47

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBRX vs. SILJ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ImmunityBio, Inc. (IBRX) and Amplify Junior Silver Miners ETF (SILJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	IBRX	SILJ	Difference
Sharpe ratio: Return per unit of total volatility	1.43	2.00	-0.57
Sortino ratio: Return per unit of downside risk	2.60	2.32	+0.28
Omega ratio: Gain probability vs. loss probability	1.31	1.32	-0.01
Calmar ratio: Return relative to maximum drawdown	3.53	3.16	+0.37
Martin ratio: Return relative to average drawdown	5.20	7.73	-2.53
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

IBRX vs. SILJ - Sharpe Ratio Comparison

The current IBRX Sharpe Ratio is 1.43, which is comparable to the SILJ Sharpe Ratio of 2.00. The chart below compares the historical Sharpe Ratios of IBRX and SILJ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	IBRX	SILJ	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.43	2.00	-0.57
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.14	0.30	-0.44
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.01	0.21	-0.22
Sharpe Ratio (All Time) Calculated using the full available price history	-0.12	0.09	-0.21

Drawdowns

IBRX vs. SILJ - Drawdown Comparison

The maximum IBRX drawdown since its inception was -97.14%, which is greater than SILJ's maximum drawdown of -79.04%. Use the drawdown chart below to compare losses from any high point for IBRX and SILJ.

Drawdown Indicators

	IBRX	SILJ	Difference
Max Drawdown Largest peak-to-trough decline	-97.14%	-79.04%	-18.10%
Max Drawdown (1Y) Largest decline over 1 year	-42.44%	-34.71%	-7.73%
Max Drawdown (3Y) Largest decline over 3 years	-79.34%	-34.71%	-44.63%
Max Drawdown (5Y) Largest decline over 5 years	-92.83%	-55.47%	-37.36%
Max Drawdown (10Y) Largest decline over 10 years	-97.03%	-70.06%	-26.97%
Current Drawdown Current decline from peak	-82.75%	-26.50%	-56.25%
Average Drawdown Average peak-to-trough decline	-83.91%	-41.43%	-42.48%
Ulcer Index Depth and duration of drawdowns from previous peaks	28.74%	14.16%	+14.58%

Volatility

IBRX vs. SILJ - Volatility Comparison

ImmunityBio, Inc. (IBRX) has a higher volatility of 22.30% compared to Amplify Junior Silver Miners ETF (SILJ) at 18.66%. This indicates that IBRX's price experiences larger fluctuations and is considered to be riskier than SILJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	IBRX	SILJ	Difference
Volatility (1M) Calculated over the trailing 1-month period	22.30%	18.66%	+3.64%
Volatility (6M) Calculated over the trailing 6-month period	88.77%	45.24%	+43.53%
Volatility (1Y) Calculated over the trailing 1-year period	105.21%	54.90%	+50.31%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	113.45%	44.33%	+69.12%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	111.38%	46.23%	+65.15%

Dividends

IBRX vs. SILJ - Dividend Comparison

IBRX has not paid dividends to shareholders, while SILJ's dividend yield for the trailing twelve months is around 1.87%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
IBRX ImmunityBio, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SILJ Amplify Junior Silver Miners ETF	1.87%	2.00%	7.26%	0.01%	0.05%	0.36%	1.23%	1.45%	1.66%	0.00%	0.52%	2.46%

Frequently Asked Questions

Can I hold both IBRX and SILJ in my portfolio?

IBRX and SILJ have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, IBRX or SILJ?

IBRX has higher volatility (22.30%) compared to SILJ (18.66%). In terms of maximum drawdown, IBRX dropped -97.14% vs SILJ's -79.04%.

Which has better risk-adjusted returns?

SILJ currently has the higher Sharpe Ratio (2.00 vs 1.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.